Francisco Rodriguez, general manager Mexico and Latin America at Mundipharma, provides an overview of the customized market approach that has allowed the company to establish itself as the partner of choice of the medical and regulatory authorities in the pain management field, and how Mundipharma now looks at replicating similar tailor-made, collaborative effort for the ophthalmology treatments it recently launched in Mexico.
You were appointed head of Latin America a little more than a year ago. How is Mundipharma organized in the region?
"In the grand scheme of things, our overarching objective is to ensure our entire portfolio is accessible to Latin American patients in all countries of the region"
